685 related articles for article (PubMed ID: 26071178)
21. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
[TBL] [Abstract][Full Text] [Related]
22. Neurofibromatosis 2 in the pediatric age group.
Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
[TBL] [Abstract][Full Text] [Related]
23. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
24. Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.
Wolkenstein P; Benchikhi H; Zeller J; Wechsler J; Revuz J
Dermatology; 1997; 195(3):228-31. PubMed ID: 9407167
[TBL] [Abstract][Full Text] [Related]
25. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
[TBL] [Abstract][Full Text] [Related]
26. Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.
Rodriguez FJ; Scheithauer BW; George D; Midha R; MacCollin M; Stemmer-Rachamimov AO
Acta Neuropathol; 2011 May; 121(5):663-8. PubMed ID: 21191601
[TBL] [Abstract][Full Text] [Related]
27. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
28. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
29. An update on the diagnosis and treatment of vestibular schwannoma.
Halliday J; Rutherford SA; McCabe MG; Evans DG
Expert Rev Neurother; 2018 Jan; 18(1):29-39. PubMed ID: 29088993
[TBL] [Abstract][Full Text] [Related]
30. Schwannomatosis: a new member of neurofibromatosis family.
Chen SL; Liu C; Liu B; Yi CJ; Wang ZX; Rong YB; Zhu J; Ding Y; Tian GL
Chin Med J (Engl); 2013 Jul; 126(14):2656-60. PubMed ID: 23876891
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis type 2 service delivery in England.
Lloyd SK; Evans DG
Neurochirurgie; 2018 Nov; 64(5):375-380. PubMed ID: 26826883
[TBL] [Abstract][Full Text] [Related]
32. The neuroimaging and clinical spectrum of neurofibromatosis 2.
Mautner VF; Lindenau M; Baser ME; Hazim W; Tatagiba M; Haase W; Samii M; Wais R; Pulst SM
Neurosurgery; 1996 May; 38(5):880-5; discussion 885-6. PubMed ID: 8727812
[TBL] [Abstract][Full Text] [Related]
33. An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis.
Adelhoefer SJ; Feghali J; Rajan S; Eberhart CG; Staedtke V; Cohen AR
Childs Nerv Syst; 2024 Jul; 40(7):2209-2214. PubMed ID: 38451298
[TBL] [Abstract][Full Text] [Related]
34. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2.
Slattery WH
Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
[TBL] [Abstract][Full Text] [Related]
36. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
[TBL] [Abstract][Full Text] [Related]
37. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Fisher MJ; Belzberg AJ; de Blank P; De Raedt T; Elefteriou F; Ferner RE; Giovannini M; Harris GJ; Kalamarides M; Karajannis MA; Kim A; Lázaro C; Le LQ; Li W; Listernick R; Martin S; Morrison H; Pasmant E; Ratner N; Schorry E; Ullrich NJ; Viskochil D; Weiss B; Widemann BC; Zhu Y; Bakker A; Serra E
Am J Med Genet A; 2018 May; 176(5):1258-1269. PubMed ID: 29681099
[TBL] [Abstract][Full Text] [Related]
38. Peripheral nerve sheath tumors in Neurofibromatosis Type 2: Surgical and histopathologic features.
Mehta GU; Huynh H; Lekovic GP
Clin Neurol Neurosurg; 2020 Mar; 190():105649. PubMed ID: 31881415
[TBL] [Abstract][Full Text] [Related]
39. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]